Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.

BMC cancer - 21 May 2014

Pérez-Holanda Sergio, Blanco Ignacio, Menéndez Manuel, Rodrigo Luis

Abstract excerpt

BACKGROUND: The association between alpha-1 antitrypsin (AAT) deficiency and colorectal cancer (CRC) is currently controversial. The present study compares AAT serum concentrations and gene frequencies between a group of CRC patients and a control group of healthy unrelated people (HUP). METHODS: 267 CRC subjects (63% males, 72 ± 10 years old) were enlisted from a Hospital Clinic setting in Asturias, Spain. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to alpha 1-Antitrypsin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to alpha 1-Antitrypsin Deficiency

Share to Biomarkers, Tumor

Share to Colorectal Neoplasms

Share to Prevalence

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 24886427
DOI: 10.1186/1471-2407-14-355
PMCID: PMC4032587

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum concentration of alpha-1 antitrypsin is significantly higher in colorectal cancer patients than in healthy controls.PMID 24886427Read ↗

Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles.Semantic proximity Read ↗

Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain.Semantic proximity Read ↗

Frequency of alleles and genotypes associated with alpha-1 antitrypsin deficiency in clinical and general populations: Revelations about underdiagnosis.Semantic proximity Read ↗

Prevalence of Alpha-1 Antitrypsin Deficiency (AATD) in a General Population of Northern Italy: A Descriptive AnalysisSemantic proximity Read ↗

The prevalence of alpha(1)-antitrypsin deficiency in a representative population sample from Poland.Semantic proximity Read ↗

α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population.Semantic proximity Read ↗

Alpha-1-antitrypsin phenotypes in adult liver disease patients.Semantic proximity Read ↗

Genotyping diagnosis of alpha-1 antitrypsin deficiency in Saudi adults with liver cirrhosis.Semantic proximity Read ↗

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.Semantic proximity Read ↗

Genotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population.Semantic proximity Read ↗

Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.